Publications by authors named "Shwe Gyaw"

Claim this Profile
R
Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder.
David J McCann, Hegang H Chen, Eric G Devine, Shwe Gyaw, Tatiana Ramey

Drug Alcohol Depend· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.
Philip Krieter, Shwe Gyaw, Roger Crystal, Phil Skolnick

J Pharmacol Exp Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.
Philip A Krieter, C Nora Chiang, Shwe Gyaw, David J McCann

J Clin Pharmacol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.
Philip Krieter, Shwe Gyaw, C Nora Chiang, Roger Crystal, Phil Skolnick

J Clin Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.
Philip Krieter, C Nora Chiang, Shwe Gyaw, Phil Skolnick, Rebekah Snyder

Drug Metab Dispos· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
Philip Krieter, Nora Chiang, Shwe Gyaw, Phil Skolnick, Roger Crystal

J Clin Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.
Yossi Gilgun-Sherki, Rom E Eliaz, David J McCann, Pippa S Loupe, Eli Eyal, Shwe Gyaw

Drug Alcohol Depend· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis